HOTCHKIS & WILEY's BMRN Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 447,200 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $25.59 M, representing 0.07% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, HOTCHKIS & WILEY has initiated a new position in BMRN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by HOTCHKIS & WILEY
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +447,200 | New Buy | 447,200 | $57.22 |
HOTCHKIS & WILEY's BioMarin Pharmaceutical Investment FAQs
HOTCHKIS & WILEY first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q2 2026, acquiring 447,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held BioMarin Pharmaceutical Inc. (BMRN) for 1 quarters since Q2 2026.
HOTCHKIS & WILEY's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q2 2026, adding 447,200 shares worth $25.59 M.
According to the latest 13F filing for Q2 2026, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 447,200 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $25.59 M.
As of the Q2 2026 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.07% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.
HOTCHKIS & WILEY's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 447,200 shares, as reported at the end of Q2 2026.